Why the study?
Does platelet cytosolic free calcium response to arginine vasopressin differ between patients with essential hypertension and normotensive controls?
Does platelet cytosolic free calcium response to arginine vasopressin differ between patients with essential hypertension and normotensive controls?
Platelet cytosolic free calcium responses to arginine vasopressin are blunted in essential hypertension, and changes in these calcium levels correlate with blood pressure reduction following antihypertensive therapy.
Blunted platelet calcium response to vasopressin in hypertension is hypothesis-generating; leaves open causal and therapeutic relevance.
Resting and stimulated free calcium concentrations have been measured in platelets loaded with the fluorescent probe quin2 from 30 patients with essential hypertension and from 30 age-matched controls. 2. Cytosolic free calcium concentrations were 94.6 +/- 2.7 (mean +/- SEM) in the hypertensive group and 91.7 +/- 2.8 nmol/l in the normotensive group, the difference was not significant. 3. Arginine vasopressin caused a transient increase in platelet free calcium concentration in all subjects. In the presence of extracellular calcium the increase was significantly higher in the control subjects than in the hypertensive patients (P = 0.005). In the absence of extracellular calcium, arginine vasopressin caused much smaller increases, and there was then no difference between the responses of the two groups. 4. Platelet free calcium concentrations were measured again in 13 patients after 8 weeks treatment with either verapamil (n = 6) or atenolol (n = 7). The reductions in systolic pressure after drug treatment were correlated with the changes in cytosolic free calcium concentrations (r = 0.75, P less than 0.01).
No takes yet. Share an insight, caveat, or question.
Dominiczak et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: